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Abstract 22q11.2 deletion syndrome (22q11DS) is a genet-
ic disorder associated with a microdeletion of chromosome
22q11. In addition to high rates of neuropsychiatric disorders
such as schizophrenia and attention deficit hyperactivity
disorder, children with 22q11DS have a specific neuropsy-
chological profile with particular deficits in visuospatial and
working memory. However, the neurobiological substrate
underlying these deficits is poorly understood. We investi-
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gated brain function during a visuospatial working memory
(SWM) task in eight children with 22q11DS and 13 healthy
controls, using fMRI. Both groups showed task-related
activation in dorsolateral prefrontal cortex (DLPFC) and
bilateral parietal association cortices. Controls activated
parietal and occipital regions significantly more than those
with 22q11DS but there was no significant between-group
difference in DLPFC. In addition, while controls had a
significant age-related increase in the activation of posterior
brain regions and an age-related decrease in anterior regions,
the 22q11DS children showed the opposite pattern. Genet-
ically determined differences in the development of specific
brain systems may underpin the cognitive deficits in
22q11DS, and may contribute to the later development of
neuropsychiatric disorders.
Keywords Velo-cardio-facial syndrome .
22q11.2 deletion syndrome . Spatial working memory .
fMRI . Ageing . Schizophrenia
Introduction
22q11.2 deletion syndrome (22q11DS), also known as
velo-cardio-facial syndrome (VCFS) is a genetic disorder
associated with a microdeletion in chromosome 22q11.2
[1]. While the physical phenotype is variable, commonly
reported features include characteristic dysmorphology,
congenital heart disease and cleft palate [2, 3]. A
characteristic behavioural phenotype in 22q11DS has also
been described with high rates of schizophrenia and
attention deficit / hyperactivity disorder (ADHD) [4–7]. In
addition, children and adults with 22q11DS typically have
mild learning disabilities and a specific cognitive profile
with particular deficits of visuospatial function, working
memory, attention, executive function [8–13].
There is increasing evidence for a robust association
between 22q11DS and schizophrenia [14]. Indeed, deletion
of chromosome 22q11 represents the most commonly
known risk factor for the development of schizophrenia
and offers a unique model for identifying the neurobiolog-
ical substrate underlying the development of psychotic
disorders. In the general population, people with schizo-
phrenia have deficits in a number of cognitive domains,
including visuospatial working memory (SWM) [15–26].
Furthermore, recent neuropsychological and neuroimaging
studies indicate that those at high-risk of developing
psychosis also show deficits in SWM [15, 27–31]. For
instance, Saperstein and colleagues compared the relative
risk ratios for SWM deficits among 23 schizophrenics, 17
relatives of patients with schizophrenia with schizophrenia
spectrum personality disorders (SSPD), 23 non-SSPD
relatives of patients with schizophrenia, 14 SSPD commu-
nity members with no family history of psychosis, and 36
healthy community controls [27]. Relative risk of SWM
deficits, as compared with healthy community controls,
increased with the relative genetic liability, where it was
highest among patients with schizophrenia, second highest
among SSPD family members, then family non-SSPD and
community SSPD. The authors suggested that the pattern of
SWM performance deficits reflected the proposed model of
latent genetic liability, upholding SWM as a viable cognitive
endophenotype [27]. Similarly, 22q11DS adults with schizo-
phrenia are significantly more impaired in a number of
cognitive domains, including spatial working memory
(SWM), as compared to those without schizophrenia [12].
The neural basis for SWM has been investigated in many
neuroimaging studies within the general population. These
reported that SWM tasks activate a cortical pathway extending
bilaterally from prefrontal cortex (more dorsal than ventral for
spatial rather than object working memory) to anterior
cingulate and parietal regions. This is true in both children
and adults [32–35]. Furthermore, relatively few studies that
have also examined the developmental changes in brain
functions during normal brain development reported that there
may be an age-related increase in brain activations in frontal
and parietal cortical areas [32, 33, 36], which is consistent
with developmental changes in the brain structure [37].
Frontal cortex may be functionally different in people
with schizophrenia. For example, many neuroimaging
studies on working memory processing in schizophrenia
report aberrant activation of prefrontal cortex although
changes have not always been consistent [20, 25, 38–43].
In addition, a recent fMRI study of brain function during a
memory-guided saccade SWM task in the offspring of
people with schizophrenia (i.e. a ‘High Risk’ group)
reported that they also had significantly reduced activation
of the DLPFC and parietal cortex as compared to controls
[29]. Thus, there is preliminary evidence that abnormalities
in the function of frontal, and perhaps parietal, cortex
during SWM tasks may precede the onset of schizophrenia.
We, and others, previously reported that people with
22q11DS have neurodevelopmental abnormalities in the
anatomy of frontal and parietal regions [44–48] and
possibly a disruption in the connectivity of the frontal–
parietal pathway [49, 50]. As noted above, in the general
population, aberrant activation of these brain regions during
SWM has been reported in people at risk of developing
psychosis [29]. However, to date nobody has examined
brain function during a SWM task in people with 22q11DS,
or examined if the functional developmental trajectory of
these regions is different. Thus, we (1) investigated the
neural functioning in children and adolescents with
22q11DS and healthy controls during a SWM task, and
(2) carried out a preliminary analysis of age-related differ-
ences in brain function.
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Methods
Subjects
We included 21 volunteers who could reliably carry out the
SWM task (eight subjects with 22q11DS and 13 healthy
controls). All were right-handed. The 22q11DS group
comprised four males and four females, aged 9–16 years
and the healthy controls included eight males and five
females, aged 8–17 years (see Table 1 for demographic data).
Where possible we used sibling-controls (eight out of 13) in
order to match as best we could for socioeconomic factors.
The sibling and non-sibling controls did not significantly
differ in FSIQ (F<1).
The 22q11DS volunteers were recruited through the
22q11 (UK) Support group and the Behavioural Genetics
Clinic at the Maudsley Hospital/Institute of Psychiatry,
Kings College London. 22q11DS was diagnosed by
fluorescence in-situ hybridisation (FISH) using the N25
probe (Oncor Inc). Eight of the control group were siblings,
and five were recruited from the local community. All the
participants, and/or their parents gave written informed
consent/assent as approved by the local research ethics
committee (Institute of Psychiatry, South London and
Maudsley Trust).
All subjects underwent routine psychiatric and phys-
ical examination, and routine blood tests. Overall
cognitive ability was measured using the Wechsler
Intelligence Scale for Children-III (WISC-III) [51]. We
excluded people with a clinically detectable co-morbid
psychiatric disorder or physical disorder affecting brain
function (e.g. ADHD, hypothyroidism, or epilepsy), or
with a clinically abnormal MRI scan—as determined by a
neuroradiologist. As expected controls had significantly
higher scores for performance IQ (PIQ), verbal IQ (VIQ),
and full scale IQ (FSIQ) (p<.001). All were drug free at
the time of testing.
Tasks
We used a Spatial Working Memory (SWM) ‘block-
design’ task, based on one developed by Klingberg et
al. [32]. In our version, ten brown, square boxes (see
Fig. 1) in random positions, instead of the original 4×4
matrix, were used as possible target locations in order to
minimize the possibility of giving verbal labels for each
location. The locations of the boxes were changed from
trial to trial.
Each trial began with the presentation of ten boxes for
500 ms to indicate the possible target locations for the trial.
A picture of an apple (target) appeared sequentially in some
of these boxes for 1,000 ms. Either three or five of the
boxes per trial were used as target locations, creating two
conditions (Fig. 2). The gaps between the presentations of
the target locations were 2,000 and 500 ms respectively for
the three and five apple conditions. This kept the overall
presentation time constant at 7,000 ms. After 2,000 ms
following the last target location, one of the boxes went
blue for another 2,000 ms. The subjects had to press one of
the two buttons to indicate whether or not this box was a
target location during this period. Then, the screen became
blank for 1,000 before the next trial began. Half the
subjects were instructed to press the left button if the blue
box was in one of the target locations and the right button
for the non-target locations. For the other subjects, the
response-to-button mapping was reversed. For button
responses, the subjects used a rectangular box (6×11 cm)
where two square buttons (1 cm2) were placed in the
middle with a gap of about 2.5 cm. They were instructed to
hold the box with their left hand and press the buttons with
their right index and middle fingers.
There was also a baseline task in which the boxes were
arranged in the shape of an “X” (see Fig. 1), with the
target locations appearing in the four corner boxes in a
predictable order. Subjects were instructed to look at the
Fig. 1 Examples of stimuli used for the SWM task and baseline task
Table 1 Profiles of subjects for each group
22q11DS Control
Variables n=8 n=13 (8)
Age range (mean±SD) 9–16 (12±2) 8–17 (13±3)
Sex: M/F 4/4 8(4)/5(4)
Performance IQ 67±7 109±20
Verbal IQ 71±15 110±17
FSIQ 67±8 114±17
COMT genotype
Val 5 0
Met 3 0
Val/Val 0 2
Val/Met 0 4
Met/Met 0 1
Unknown 0 6
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target as it appears in different locations, and then press a
pre-specified button when one of the boxes in the middle
was highlighted in blue. This way, both tasks had the
components of visual stimulation, eye movements and
motor output, while the SWM task had an extra compo-
nent of SWM.
There were two runs of ten blocks each where the
subjects alternated between the baseline block and SWM
block (10 blocks×baseline; 5 blocks×swm3; 5 blocks×
swm5 in total). There were three trials of the same
condition (i.e. baseline, swm3, swm5) in each block, and
a brief message at the beginning of each block indicated
whether it was to be a baseline block or a SWM block. The
two conditions of the SWM task (i.e. three-targets or five
targets) were distributed in pseudo-random order.
Practice
Prior to the scan, all the subjects completed an offline
version of the SWM task to practise the task. The subjects
were first given a block of ten SWM trials with just two
target locations. This was repeated until the subjects could
respond with an accuracy rate of more than 80%. Then, the
subjects completed the eight blocks of ten SWM trials. The
number of target locations for each block increased from
two to eight. The target stimuli were presented at the fixed
rate of 1,000 ms presentation time and 1,000 ms interval.
For each trial, an auditory feedback (a high or low tone)
was given to indicate whether or not the response made was
correct. After completing the offline task, the subjects were
given four blocks of the scanning version of the task to get
familiarised with the setting.
Image acquisition
All functional imaging data were acquired at 1.5 T using a
GE, Neuro-optimised MR System (General Electric Health-
care, Milwaukee, WI) based at the Maudsley Hospital,
London. A quadrature birdcage headcoil was used for radio
frequency transmission and reception. An inversion recov-
ery echoplanar imaging (EPI) dataset was acquired at 43
near-axial 3 mm thick planes parallel to the anterior
commissure–posterior commissure (AC-PC) line: time-to-
echo (TE) 73 ms, inversion time (TI) 180 ms, repetition
time (TR) 16 s, in-plane resolution 1.72 mm, interslice gap
0.3 mm, matrix size: 128×128 pixels. This higher resolu-
tion EPI dataset provided whole brain coverage and was
later used to register the fMRI datasets acquired from each
individual in standard stereotactic space. 16 near-axial non-
contiguous slices (7-mm thick, 0.7-mm slice skip) were
prescribed parallel to the anterior commissure–posterior
commissure (AC-PC) line and covering the whole brain:
TE 40 ms, TR 2 s, in-plane resolution 3.44 mm, interslice
gap .7 mm, matrix size: 64×64 pixels.
For each experimental series, 220 T2*-weighted, echo-
planar images depicting Blood Oxygenation Level Depen-
Fig. 2 SWM task performed during the fMRI scan. For the SWM
task (top two), subjects had to remember the positions of the boxes in
which an apple (target) was presented sequentially. After 2,000 ms of
delay following the presentation of the target in the final box for a
given trial, one of the boxes was highlighted, and the subjects pressed
a button to indicate whether or not the target had appeared in this box.
For the “memory load=3” condition, the target was presented in three
of the ten boxes, whereas for the “memory load=5” condition, five
boxes were used target locations. For the baseline task (bottom), the
stimuli were presented sequentially in the predictable order (i.e. top-
left, top-right, bottom-left, bottom-right). When the middle box was
highlighted after the delay, subjects pressed the pre-specified button
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dent (BOLD) contrast [52] were collected from each slice at
an echo time (TE) of 40 ms and a repetition time (TR) of 2 s.
Four dummy acquisitions were acquired at the beginning of
each series to ensure that the spin system had reached steady
state and the chosen flip angle was 70° and number of
averages (NEX)=1.
Visual Stimuli were presented via a conventional PC and
LCD projector system to a screen placed at the feet of the
subject and overt responses were made using an MR
compatible two-button box placed in the subject’s dominant
right hand. Presentation of all stimuli and recording of all
subject responses were synchronised to the imaging system.
The total functional image acquisition time for each series
was 7 min 28 s.
Neuroimaging data analysis
Individual brain activation maps
Data were analysed using a non-parametric approach with
XBAM, the local software developed at the Institute of
Psychiatry [53]. The images were first processed to
minimize motion related artefacts [54]. They were then
smoothed using a Gaussian filter (FWHM 7.2 mm) to
improve the signal to noise characteristics of the images.
Responses to the experimental paradigms were then
detected by first convolving each component of the
experimental design with each of two gamma variate
functions (peak responses at 4 and 8 s respectively). The
best fit between the weighted sum of these convolutions
and the time series at each voxel was computed using the
constrained BOLD effect model suggested by Friman et al.
[55]. A goodness of fit statistic was computed, consisting of
the ratio of the sum of squares of deviations from the mean
image intensity (over the whole time series) due to the
model to the sum of squares of deviations due to the
residuals (SSQratio).
The data were then permuted by the wavelet-based
method described and extensively characterized in Bullmore
et al. [56]. Using this distribution, it is possible to calculate
the critical value of SSQratio needed to threshold the maps at
any desired type I error rate. The detection of activated
voxels is extended from voxel to cluster level using the
method described in detail by Bullmore et al. [57].
Group brain activation maps
The observed and randomised data for each individual are
transformed into the standard Talairach space [58] using the
procedure described in detail in Brammer et al. [53]. Group
activation maps are then computed by determining the
median SSQratio at each voxel (over all individuals) in the
observed and permuted data maps (medians are used to
minimize outlier effects). Analysis was extended from
voxel to cluster level by the permutation method described
by Bullmore et al. [57] and the expectation false positive
clusters set to <1 per brain.
Between group analysis
Group differences were estimated on a voxel-wise basis across
the whole brain by fitting a regression model of the type
y ¼ a þ bX þ e
to the data at each voxel. In this formulation, y represents a
vector of individual subject SSQratios at each voxel in
standard space, X is a group contrast matrix and e is a vector
of residual errors at each voxel. The estimate of the
parameter b describes the magnitude of the group difference.
The significance of these estimates of b is determined by
permutation as follows. The elements of the contrast matrix
X are permuted to give a random assignment of subjects to
each group and the model refitted. Repeating this procedure
a large number of times at each voxel and subsequently
combining the estimates of b over all voxels produces the
distribution of b under the null hypothesis of no effect of
group membership on activation. Observed values of b in the
unpermuted data can then be tested against this distribution
to assess their probability under the null hypothesis. This
analysis is also extended to the cluster level as previously
described (Bullmore et al. [54]).
Correlations of age and brain activities
We also conducted a correlation analysis to examine age-
related differences in brain functions associated with SWM
in 22q11DS and controls, then contrasted the trajectories
between the groups. Correlational analysis is carried out by
computing the Pearson product-moment correlation coeffi-
cient at every voxel between the subject ages and statistical
values (SSQ ratios). The significance of this correlation at
whole brain level is determined by permuting the order of
subjects 50 times at each voxel and re-determining the
correlation coefficient. Combining the correlation coefficients
following permutation over the whole brain gives us the null
distribution of correlation coefficients. The significance of the
observed (pre-permutation) correlation coefficients is then
determined at voxel and cluster level using the data-driven
null distribution produced as described above.
Group comparison of age correlations
In order to compare the age-correlation (i.e. developmental
differences) between the groups, the Pearson product-
moment correlation coefficient was calculated for each
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group independently and the difference between the
correlation coefficients was then computed. To test the
significance of this difference, the behavioural data were
randomly permuted between the two groups and the above
calculation procedure repeated. The permutation/calculation
procedure was repeated 50 times at each voxel and the
resulting data combined over all voxels to form a “global”
distribution of correlation coefficient differences under the
null hypothesis of no difference between the correlation
between behaviour and BOLD response in the two groups.
The significance of any observed difference in correlation
in the original data could then be assessed by reference to
this distribution.
Results
Task performance
For each subject, task performance was assessed as the
percentage of correct responses for the SWM task. Since
the accuracy levels for the SWM tasks and the baseline task
did not significantly differ between the sibling and non-
sibling controls, and neither of them have a deletion in
22q11.2, data from both sibling and non-sibling healthy
children have been analysed together as the healthy control
group. The task performance for the 22q11DS group was
73(±16)% and 79(±12)% for the target=3 and target=5
conditions, respectively, whereas, these were 88(±10)% and
88(±10)% in the healthy control group. The accuracy level
for the baseline task was 97(±5)% for the 22q11DS group
and 96(±6)% for the control group. An analysis of variance
(ANOVA) (group × task type) on the accuracy revealed
there was a significant main effect of group (F(1, 57)=8.0,
p<0.01); the main effect of task type (F(2, 57)=13.2,
p<0.001); but the interaction was not significant (F(2, 57)=
2.9, p=0.06). The main effect of group indicated that the
overall performance accuracy was significantly higher in
the controls. A post-hoc analysis suggested that in both
groups the accuracy rates for the baseline task was higher
than those for the SWM tasks. There was no significant
effect of memory load (swm3 and swm5) on performance
accuracy.
Image data analysis
Since there was no difference in brain activations between
the target=3 and target=5 conditions data from the two
conditions were combined in order to increase statistical
power. An averaged activation map image (voxel p=0.05;
cluster p=0.01) was created for each group (see Fig. 3). At
this level of stringency there was less than one false
positive cluster for each analysis. Table 2 shows the areas
activated significantly more during the SWM task than
during the baseline task for each group.
Group comparison
Both groups significantly activated brain regions normally
associated with SWM processes, such as, DLPFC, parietal
regions, as well as primary visual regions in the occipital
lobule (Fig. 4 and Table 3). We compared group activation
using an analysis of variance (voxel p=0.01; cluster p=
0.01) on the “SWM activation—baseline activation” data.
At this level of stringency there was less than one false
positive cluster for analysis. Controls had significantly
greater activation than people with 22q11DS (Table 3)
bilaterally in precuneus (BA 7, 31), and right cuneus (BA
18). In order to see if differences in parietal activation could
have been related to significant differences in task
performance, we have carried out correlation analysis
between task performance accuracy and brain activities.
(see Fig. 4). Significantly positive correlation between task
performance and parietal activities was found in the left
precuneus (BA 7) in the 22q11DS group but absent in the
controls. In contrast, significantly negative correlations was
found in the left inferior parietal lobule (BA 40) in the
controls. Thus, it was unlikely that the significant group
differences in the parietal region were attributable to higher
performance in the controls. Indeed, the overall pattern of
group differences remained even when we re-ran the same
Fig. 3 Brain activation maps for the 22q11DS group (above) and the
control group (below). The red/yellow areas indicate regions where
there was significant activation during the SWM task as compared to
the baseline task (voxel p=0.05, cluster p=0.01)
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Table 2 Brain regions where the clusters of more than five voxels were activated during the SWM task for each subject groups (voxel p=0.05,
cluster p=0.01)
Area Brain region 22q11DS Normal control
Coordinates BA Voxels (n) Coordinates BA Voxels (n)
X Y Z X Y Z
Frontal Dorsolateral prefrontal cortex
Right 40 33 26 9 45 43 4 20 9 71
40 37 15 46 22 40 33 9 46 41
Middle frontal gyrus
Right 25 −7 42 6 25 32 4 42 6 39
40 37 20 10 25
Superior frontal gyrus
Right 29 56 −2 10 20
Precentral gyrus
Right 47 0 26 6 33
47 7 9 44 7
Parietal Precuneus
Left −18 −67 42 7 11 −14 −63 37 7 63
−22 −70 31 19 60
−18 −67 26 31 43 −22 −70 26 31 38
Right 22 −63 48 7 31 18 −63 48 7 102
29 −74 31 19 20 29 −70 31 19 60
25 −70 26 31 46
Supramarginal gyrus
Right 36 −44 31 40 7
Superior parietal lobule
Right 22 −63 42 7 29
Temporal Superior temporal gyrus
Right 47 −44 9 22 10
Fusiform gyrus
Left −47 −67 −18 19 26
Occipital Fusiform gyrus
Left −22 −70 31 19 61 −40 −74 −13 19 34
Right 29 −70 26 19 39 32 −74 −18 19 35
Cuneus
Right 25 −78 9 17 17 25 −67 20 18 37
29 −74 9 30 25
Inferior occipital gyrus
Left −36 −81 −2 18 10 −32 −74 −2 19 40
Right 40 −74 −2 19 16
Middle occipital gyrus
Left −32 −78 15 19 26 −36 −70 4 19 32
Right 29 −78 15 19 27 36 −74 4 19 27
Lingual gyrus
Left −22 −81 −2 18 5
Right 25 −78 −2 18 19
Limbic Posterior cingulate gyrus
Left −22 −63 20 31 21
Right 29 −59 20 31 26
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analysis, and covaried for task accuracy. The 22q11DS
group did not have significantly greater activation than
controls in any brain region. Contrary to our expectation,
there was no significant between-group difference in
activation of DLPFC.
Age correlation
Increased activation with age In the 22q11DS group (voxel
p=0.005; cluster p=0.01; false positive cluster <1) there
was a significant age-related increase in the left VLPFC
(BA 47), superior frontal gyrus (BA 6), middle occipital
gyrus (BA 18), and right precuneus (BA 7) (Fig. 5 and
Tables 4 and 5). In contrast the healthy control group had a
significant age-related increase in bilateral superior parietal
lobule (BA 7), left precuneus (BA 7), inferior parietal
lobule (BA 40), fusiform gyrus (BA 37), inferior temporal
gyrus (BA 20), middle-inferior occipital gyrus (BA 19),
posterior cingulate gyrus (BA 31), right middle frontal
gyrus (BA 10), and angular gyrus (BA 39). (see Fig. 4 and
Table 4).
Decreased activation with age There was also a significant
negative correlation (voxel p=0.005; cluster p=0.01; false
positive cluster <1) between age and decreased brain
activations. For the healthy controls, most of the age-
related decrease was observed in frontal areas (e.g. bilateral
VLPFC, middle frontal gyri, left DLPFC, and right
precentral gyrus). In contrast, the 22q11DS group showed
an age-related decrease mostly in non-frontal areas, such as
bilateral parietal regions, fusiform gyri, cingulate gyri, right
temporal regions and parahippocampal gyrus. (see Fig. 4
and Table 5).
Group differences in age effect There were significant
differences between the 22q11DS and control groups in
the developmental trajectories of brain activations for SWM
(see Table 6).
Fig. 4 Areas that showed significant correlation between task performance and brain activations were observed (voxel p=0.05, cluster p=0.01)
Table 2 (continued)
Area Brain region 22q11DS Normal control
Coordinates BA Voxels (n) Coordinates BA Voxels (n)
X Y Z X Y Z
Insula
Right 29 26 −2 13 19
47 7 15 13 15
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Overall, the controls showed significantly larger age-related
changes in brain activations (both increase and decrease)
than 22q11DS in widespread cortical and subcortical
regions, predominantly in the right hemisphere (e.g. middle
frontal gyrus (BA 25), inferior parietal lobule (BA 40),
superior temporal gyrus (BA 42), parahippocampal gyrus
(BA 36), hippocampus, caudate, and brain stem), as well as
bilateral inferior frontal gyrus (BA11), and left thalamus
and cerebellum. The 22q11DS group, in contrast, showed
larger correlational changes than the controls in the left
inferior frontal gyrus (BA 44), and caudate only.
Discussion
We investigated brain function during a SWM task in
children and adolescents with 22q11DS, and healthy
controls. Both groups showed activation of the DLPFC,
parietal and occipital regions during performance of the
visual SWM task. However, healthy controls had
significantly greater activation than children with
22q11DS, in parietal and occipital regions with no
significant difference in activation of frontal regions
between both groups.
Fig. 5 Areas that showed age-related change in brain activation were observed (voxel p=0.005; cluster p=0.01)
Table 3 Brain regions where larger activations were observed for the control group than for the 22q11DS group (voxel p=0.01, cluster p=0.01)
Area Brain region Control > VCFS Control > VCFS (covariated)
Coordinates BA Voxels (n) Coordinates BA Voxels (n)
X Y Z X Y Z
Parietal Precuneus
Right 22 −67 37 7 44 22 −63 37 7 48
Left −29 −44 42 7 37 −29 −44 42 7 45
Superior parietal lobule
Right 22 −67 42 7 43
Occipital Cuneus
Right 25 −67 20 18 18 25 −78 20 18 17
Precuneus
Right 25 −74 15 31 9
Left −25 −70 20 31 5
Limbic Cingulate gyrus
Right 29 −70 15 30 7
Minimum cluster size=5 voxels
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Several prior studies have reported that people with
22q11DS have differences in the anatomy of frontal regions
[44–48]. In addition, people with schizophrenia and non-
22q11DS ‘high risk’ groups are reported to have signif-
icant differences in activation of the DLPFC and parietal
cortex [29]. Hence, we anticipated to find functional
differences in these brain regions in people with 22q11DS
(who are also at risk for developing schizophrenia). In
agreement with Keshavan et al., [29], we found a
significant difference in the activation of parietal regions,
but not DLPFC. In an fMRI study on 22q11DS employing
a task that requires frontal and parietal activation (i.e.
arithmetic task), Eliez and colleagues [59] also found
significant differences in the parietal, but no difference in
the prefrontal region, suggesting that the findings from both
studies are consistent.
Absence of group differences in PFC may simply mean
that they could not be detected because of the relatively
small sample size in the 22q11DS group (n=8) with 1.5 T
magnet in the current study, as well as in the study by Eliez
et al. [59]. However, potential biological explanations
include genetically determined differences in brain anato-
my. Significant differences in the anatomy of various brain
regions have been reported in young people with 22q11DS.
For instance, recent imaging studies report that 22q11DS
children and adolescents have a significantly reduced
volume of grey matter in the parietal lobe, but a
proportionally larger frontal lobe [44, 45]. Hence, reduced
parietal activation may be explained by a regionally specific
reduction in brain volume. In contrast, we may have found
no difference in activation of DLPFC because the frontal
structures may be relatively preserved, and hence, people
Table 4 Brain regions where age-related increase was observed in each group (voxel p=0.005, cluster p=0.01)
Area Brain region Age-related increase
22q11DS Normal control
Coordinates BA Voxels (n) Coordinates BA Voxels (n)
X Y Z X Y Z
Frontal Ventrolateral prefrontal cortex
Left −18 19 −13 47 12
Middle frontal gyrus
Right 32 56 9 10 7
Superior frontal gyrus
Left −4 11 48 6 11
Parietal Precuneus
Left −18 −63 42 7 6
Right 22 −70 42 7 17
Inferior parietal lobule
Left −32 −44 37 40 14
Superior parietal lobule
Left −29 −48 42 7 8
Right 25 −63 48 7 10
Angular gyrus
Right 29 −59 37 39 5
Temporal Fusiform gyrus
Left −47 −56 −18 37 7
Inferior temporal gyrus
Left −51 −52 −13 20 24
Occipital Inferior occipital gyrus
Left −36 −78 −7 19 28
Middle occipital gyrus
Left −29 −81 −7 18 5 −40 −74 9 19 8
Limbic Posterior cingulate gyrus
Left −25 −67 20 31 5
Minimum cluster size=5 voxels
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with 22q11DS become increasingly dependent on this
region as previously suggested [59].
Alternatively, disruption in the ‘connectivity’ within the
cortical network which underpins SWM, may explain our
results. For example, in the healthy population DLPFC and
parietal regions are activated during SWM tasks [60–62].
Also, Barnea-Goraly and colleagues [49] recently reported
that people with 22q11DS have disrupted ‘connectivity’ (as
measured using diffusion tensor imaging (DTI)) between
frontal, parietal, and temporal regions. Thus, our finding of
reduced activation in parietal regions may be explained by
disrupted parietal ‘connectivity’. In order to address this
issue directly we plan further DTI studies in these subjects.
There is also a potential genetic explanation for the
absence of significant differences in frontal activation be-
tween 22q11DS people and controls. Recent studies suggest
that the gene coding for catechol-O-methyltransferase
(COMT), which maps to the deleted region of 22q11 in
22q11DS, has neurobiological effects on the prefrontal
cortex [63–70]. Egan and colleagues [70] reported that the
Val (high-activity) COMT allele is associated with impaired
prefrontal cortical function in both healthy populations and
people with schizophrenia, while additional studies have
reported that the low-activity Met allele is associated with
superior prefrontal cortical function in both groups [69–71].
However, the effect of the low activity Met allele in people
Table 5 Brain regions where age-related decrease was observed in each group (voxel p=0.005; cluster p=0.01)
Area Brain area Age-related decrease
22q11DS Normal control
Coordinates BA Voxels (n) Coordinates BA Voxels (n)
X Y Z X Y Z
Frontal Dorsolateral prefrontal cortex
Left −14 48 20 9 6
Venrtolateral prefrontal cortex
Left −47 26 9 45 8
Right 43 33 −7 47 9
Middle frontal gyrus
Left −11 30 42 8 6
Right 0 −19 48 6 27
43 37 −13 11 5
Precentral lobule
Right 11 −30 53 6 18
Parietal Precuneus
Left −14 −48 37 7 6
Right 25 −37 26 31 11
Inferior parietal lobule
Right 47 −30 31 40 6
Temporal Fusiform gyrus
Right 32 −48 −13 37 19
Middle temporal gyrus
Right 36 0 −24 21 5
Superior temporal gyrus
Right 61 −30 20 42 8
Occipital Fusiform gyrus
Left −18 −52 −13 19 5
Right 36 −44 −7 37 14
Limbic Cingulate gyrus
Left −4 7 31 24 10
Right 18 −33 37 31 5 4 −33 42 31 25
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in 22q11DS remains unclear. There has been evidence that
22q11DS people with the Met allele perform significantly
better [72] than those with the Val allele on executive function
tasks which activate prefrontal regions (i.e. set-shifting, verbal
fluency, attention, and workingmemory). Conversely, Gothelf
and colleagues [73] reported that the low-activity Met allele
is a risk factor for both the decline in prefrontal cortical
volume and the consequent development of psychotic
symptoms during adolescence in people with 22q11DS.
Our current sample size is too small (22q11DS subjects with
Met allele=3; those with Val allele=5) to examine the
possible effect of the COMT Val108/158Met polymorphism in
22q11DS, but we plan to address this issue in a future study.
Our study has some limitations. For example, the sample
size was relatively small, which may account for the absence
of group differences in the DLPFC. In addition, the controls
were significantly more intelligent than people with 22q11DS,
and the accuracy rate in the control group was approximately
20% higher than that in the 22q11DS group. Hence, it may be
suggested that our results may be explained simply by
differences in ability to perform the task, and/or it might have
been better to have included an IQ matched non-deleted
control group who were also matched on social and
environmental factors. However, we compared people with
22q11DS to healthy controls (siblings of the 22q11DS
subjects, where available) because our question was how
brain activation in people with 22q11DS differs from the
general population. Also, both groups activated brain
regions which have been reported by others to be specifically
implicated in SWM processing in both children and adults
[32–35]. Hence, we were able to determine that our task was
valid. In addition, the between-group differences remained
even when we covaried for accuracy rate. Furthermore,
unrelated learning disabled controls would most likely have
comprised a heterogeneous population with a large variety of
genetic and environmental/social differences. Hence, where
possible we used sibling controls to account, as best we could,
for environmental and social differences. Thus, the signifi-
Table 6 Brain regions where significant differences in regression coefficient in age correlation was observed between 22q11DS and controls
(voxel p=0.05; cluster p=0.005)
Area Brain region Controls > 22q11DS 22q11DS > controls
Coordinates BA Voxels (n) Coordinates BA Voxels (n)
X Y Z X Y Z
Frontal Inferior frontal gyrus
Right 7 15 −18 11 9
Left −22 33 −18 11 9 −51 0 20 44 6
Middle frontal gyrus
Right 11 19 −13 25 8
Parietal Inferior parietal lobule
Right 47 −52 42 40 6
Postcentral gyrus
Right 51 −19 26 2 10
Temporal Superior temporal gyrus
Right 58 −26 15 42 19
Limbic Parahippocampal gyrus
Right 22 −33 −13 36 7
Hippocampus
Right 29 −26 −7 9
Sub-lobar Caudate
Right 22 −22 20 9
Left −11 22 4 5
Thalamus
Left −7 −22 20 7
Brainstem
Right 11 −11 −7 7
Cerebellum
Left −4 −30 −13 6
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cantly higher activations in the healthy control group probably
cannot be solely attributed to the better task performance or
environmental and/or socio-economic factors.
In addition to the group differences in brain activation
patterns, we also found preliminary evidence that people with
22q11DS may have differences in the developmental trajec-
tories of brain function during SWM tasks. Within the healthy
control group, an age-related increase in brain activations was
observed largely in the posterior regions (e.g. bilateral
superior parietal lobule, right angular gyrus, left inferior
parietal lobule, precuneus, fusiform gyrus, inferior temporal
gyrus, inferior-middle occipital gyrus) and a decrease mostly
in the anterior regions (e.g. bilateral VLPFC, middle frontal
gyri, left DLPFC, right precentral gyrus). In contrast, people
with 22q11DS people tended to use more anterior (e.g. left
VLPFC), and less posterior (e.g. bilateral precuneus,
fusiform gyri, cingulate gyri), regions as they grow older.
The age-related increases we found in the frontal and parietal
cortical regions of controls are similar to findings from
previous studies in normally developing children [32, 33].
Furthermore, a preliminary analysis of between-group differ-
ences in ageing indicated that there are significant differ-
ences between the developmental trajectories in the brain
functions associated with SWM. Thus, our findings may
provide preliminary evidence that, as people with 22q11DS
develop, they do not undergo the normal age-related ‘shift’
to activating more posterior brain regions during SWM tasks,
and instead continue to activate more anterior (frontal)
systems. The biological basis of this putative difference in
post-natal brain maturation is unknown.
In summary, we examined brain function in children with
22q11DS during a visuospatial working memory task. Both
groups activated brain regions classically implicated in
carrying out the task. However, healthy controls had
significantly greater activation than children with 22q11DS
of parietal and occipital regions. In addition, we found no
significant between-group difference in activation of frontal
regions. The neurobiological basis for our findings is
unknown, but we suggest that it may reflect neurodevelop-
ment differences in brain anatomy and connectivity. Further
work is required, and in larger samples, to examine this issue.
Acknowledgements The authors would like to thank all the young
people with and without 22q11DS who took part in the study, the
22q11 (UK) Support Group for their help and support in recruitment
and the radiographers in the Department of Neuroimaging at the
Maudsley Hospital for their expertise and work in acquiring the scans.
Reference
1. Scambler P, Carey A, Wuse R, Roach S, Dumanski J, Nordenskjold
M, Williamson R. Microdeletions within 22q11 associated with
sporadic and familial DiGeorge syndrome. Genomics 1991;10:201–6.
2. Gothelf D, Frisch A, Munitz H, Rockah R, Laufer N, Mozes T,
Hermesh H, Weizman A, Frydman M, Gothelf D, Frisch A,
Munitz H, Rockah R, Laufer N, Mozes T, Hermesh H, Weizman A,
Frydman M. Clinical characteristics of schizophrenia associated
with velo-cardio-facial syndrome. Schizophr Res 1999;35:105–12.
3. Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman
MD, Argamaso RV, Young D. A new syndrome involving cleft
palate, cardiac anomalies typical facies and learning disabilities:
velo-cardio-facial syndrome. Cleft Palate J 1978;15:15–62.
4. Murphy KC, Jones LA, Owen MJ, Murphy KC, Jones LA, Owen
MJ. High rates of schizophrenia in adults with velo-cardio-facial
syndrome. Arch Gen Psychiatry 1999;56:940–5.
5. Papolos DF, Faedda GL, Veit S, Goldberg R, Morrow B,
Kucherlapati R, Shprintzen RJ, Papolos DF, Faedda GL, Veit S,
Goldberg R, Morrow B, Kucherlapati R, Shprintzen RJ. Bipolar
spectrum disorders in patients diagnosed with velo-cardio-facial
syndrome: does a hemizygous deletion of chromosome 22q11 result
in bipolar affective disorder? Am J Psychiatr 1996;153:1541–7.
6. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ. Psychotic
illness in patients diagnosed with velo-cardio-facial syndrome and
their relatives. J Nerv Ment Dis 1994;182:476–8.
7. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW,
Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW.
Late-onset psychosis in the velo-cardio-facial syndrome. Am J
Med Genet 1992;42:141–2.
8. Henry JC, van Amelsvoort T, Morris RG, Owen MJ, Murphy DG,
Murphy KC. An investigation of the neuropsychological profile in
adults with velo-cardio-facial syndrome (VCFS). Neuropsycholo-
gia 2002;40:471–8.
9. Moss EM, Batshaw ML, Solot CB, Gerdes M, McDonald-
McGinn DM, Driscoll DA, Emanuel BS, Zackai EH, Wang PP,
Moss EM, Batshaw ML, Solot CB, Gerdes M, McDonald-
McGinn DM, Driscoll DA, Emanuel BS, Zackai EH, Wang PP.
Psychoeducational profile of the 22q11.2 microdeletion: a
complex pattern. J Pediatr 1999;134:193–8.
10. Swillen A, Devriendt K, Legius E, Eyskens B, Dumoulin M,
Gewillig M, Fryns JP. Intelligence and psychosocial adjustment in
velocardiofacial syndrome: a study of 37 children and adolescents
with VCFS. J Med Genet 1997;34:453–8.
11. Swillen A, Vogels A, Devriendt K, Fryns JP. Chromosome 22q11
deletion syndrome: update and review of the clinical features,
cognitive–behavioral spectrum, and psychiatric complications.
Am J Med Genet 2000;97:128–35.
12. van Amelsvoort T, Henry J, Morris R, Owen M, Linszen D,
Murphy K, Murphy D, van Amelsvoort T, Henry J, Morris R,
Owen M, Linszen D, Murphy K, Murphy D. Cognitive deficits
associated with schizophrenia in velo-cardio-facial syndrome.
Schizophr Res 2004;70:223–32.
13. Lewandowski KE, Shashi V, Berry PM, Kwapil TR.
Schizophrenic-like neurocognitive deficits in children and ado-
lescents with 22q11 deletion syndrome. Part B, neuropsychiatric
genetics: the official publication of the International Society of
Psychiatric Genetics. Am J Med Genet 2007;144:27–36.
14. Murphy KC. Schizophrenia and velo-cardio-facial syndrome.
Lancet 2002;359(9304):426–30.
15. Smith CW, Park S, Cornblatt B, Smith CW, Park S, Cornblatt B.
Spatial working memory deficits in adolescents at clinical high
risk for schizophrenia. Schizophr Res 2006;81:211–5.
16. Fleming K, Goldberg TE, Binks S, Randolph C, Gold JM,
Weinberger DR. Visuospatial working memory in patients with
schizophrenia. Biol Psychiatry 1997;41:43–9.
17. Goldman-Rakic PS. The physiological approach: functional
architecture of working memory and disordered cognition in
schizophrenia. Biol Psychiatry 1999;46:650–61.
18. Harvey PD, Powchik P, Mohs RC, Davidson M. Memory
functions in geriatric chronic schizophrenic patients: a neuropsy-
58 J Neurodevelop Disord (2009) 1:46–60
chological study. Journal of Neuropsychiatry & Clinical Neuro-
sciences 1995;7:207–12.
19. Keefe RS, Lees-Roitman SE, Dupre RL. Performance of patients
with schizophrenia on a pen and paper visuospatial working
memory task with short delay. Schizophr Res 1997;26:9–14.
20. Kindermann SS, Brown GG, Zorrilla LE, Olsen RK, Jeste DV.
Spatial working memory among middle-aged and older patients
with schizophrenia and volunteers using fMRI. Schizophr Res
2004;68:203–16.
21. Park S, Holzman PS. Schizophrenics show spatial working
memory deficits. Arch Gen Psychiatry 1992;49:975–82.
22. Park S, Puschel J, Sauter BH, Rentsch M, Hell D. Spatial working
memory deficits and clinical symptoms in schizophrenia: a 4-
month follow-up study. Biol Psychiatry 1999;46:392–400.
23. Salame P, Danion JM, Peretti S, Cuervo C. The state of
functioning of working memory in schizophrenia. Schizophr Res
1998;30:11–29.
24. Thermenos HW, Goldstein JM, Buka SL, Poldrack RA, Koch JK,
Tsuang MT, Seidman LJ. The effect of working memory
performance on functional MRI in schizophrenia. Schizophr Res
2005;74:179–94.
25. Lee J, Folley BS, Gore J, Park S. Origins of spatial working
memory deficits in schizophrenia: an event-related FMRI and
near-infrared spectroscopy study. PLoS ONE 2008;3:e1760.
26. Glahn DC, Therman S, Manninen M, Huttunen M, Kaprio J,
Lonnqvist J, Cannon TD. Spatial working memory as an
endophenotype for schizophrenia. Biol Psychiatry 2003;53:624–6.
27. Saperstein AM, Fuller RL, Avila MT, Adami H, McMahon RP,
Thaker GK, Gold JM. Spatial working memory as a cognitive
endophenotype of schizophrenia: assessing risk for pathophysio-
logical dysfunction. Schizophr Bull 2006;32:498–506.
28. Cannon TD, Huttunen MO, Lonnqvist J, Tuulio-Henriksson A,
Pirkola T, Glahn D, Finkelstein J, Hietanen M, Kaprio J, Koskenvuo
M. The inheritance of neuropsychological dysfunction in twins
discordant for schizophrenia. Am J Hum Genet 2000;67:369–82.
29. Keshavan MS, Diwadkar VA, Spencer SM, Harenski KA, Luna B,
Sweeney JA. A preliminary functional magnetic resonance
imaging study in offspring of schizophrenic parents. Prog Neuro-
psychopharmacol Biol Psychiatry 2002;26:1143–9.
30. Wood SJ, Pantelis C, Proffitt T, Phillips LJ, Stuart GW, Buchanan
JA, Mahony K, Brewer W, Smith DJ, McGorry PD, Wood SJ,
Pantelis C, Proffitt T, Phillips LJ, Stuart GW, Buchanan JA,
Mahony K, Brewer W, Smith DJ, McGorry PD. Spatial working
memory ability is a marker of risk-for-psychosis. Psychol Med
2003;33:1239–47.
31. Brewer WJ, Wood SJ, Phillips LJ, Francey SM, Pantelis C, Yung
AR, Cornblatt B, McGorry PD. Generalized and specific cognitive
performance in clinical high-risk cohorts: a review highlighting
potential vulnerability markers for psychosis. Schizophr Bull
2006;32:538–55.
32. Klingberg T, Forssberg H, Westerberg H. Increased brain activity
in frontal and parietal cortex underlies the development of
visuospatial working memory capacity during childhood. J Cogn
Neurosci 2002;14:1–10.
33. Kwon H, Reiss AL, Menon V. Neural basis of protracted
developmental changes in visuo-spatial working memory. Proc
Natl Acad Sci USA 2002;99:13336–41.
34. Nelson CA, Monk CS, Lin J, Carver LJ, Thomas KM, Truwit CL.
Functional neuroanatomy of spatial working memory in children.
Dev Psychol 2000;36:109–16.
35. Thomas KM, King SW, Franzen PL, Welsh TF, Berkowitz AL,
Noll DC, Birmaher V, Casey BJ. A developmental functional MRI
study of spatial working memory. Neuroimage 1999;10:327–38.
36. Rypma B, D’Esposito M. Isolating the neural mechanisms of age-
related changes in human working memory. Nat Neurosci
2000;3:509–15.
37. Lenroot RK, Giedd JN. Brain development in children and
adolescents: insights from anatomical magnetic resonance imag-
ing. Neurosci Biobehav Rev 2006;30:718–29.
38. Berman KF, Zec RF, Weinberger DR. Physiologic dysfunction of
dorsolateral prefrontal cortex in schizophrenia. II. Role of
neuroleptic treatment, attention, and mental effort. Arch Gen
Psychiatry 1986;43:126–35.
39. Callicott JH, Ramsey NF, Tallent K, Bertolino A, Knable MB,
Coppola R, Goldberg T, van Gelderen P, Mattay VS, Frank JA,
Moonen CT, Weinberger DR. Functional magnetic resonance
imaging brain mapping in psychiatry: methodological issues
illustrated in a study of working memory in schizophrenia.
Neuropsychopharmacology 1998;18:186–96.
40. Stevens AA, Goldman-Rakic PS, Gore JC, Fulbright RK, Wexler
BE. Cortical dysfunction in schizophrenia during auditory word
and tone working memory demonstrated by functional magnetic
resonance imaging. Arch Gen Psychiatry 1998;55:1097–103.
41. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC,
Halpern E, Saper CB, Rauch SL. Schizophrenic subjects show
aberrant fMRI activation of dorsolateral prefrontal cortex and
basal ganglia during working memory performance. Biol Psychi-
atry 2000;48:199–09.
42. Walter H, Wunderlich AP, Blankenhorn M, Schafer S, Tomczak R,
Spitzer M, Gron G. No hypofrontality, but absence of prefrontal
lateralization comparing verbal and spatial working memory in
schizophrenia. Schizophr Res 2003;61:175–84.
43. Koenigsberg HW, Buchsbaum MS, Buchsbaum BR, Schneiderman
JS, Tang CY, New A, Goodman M, Siever LJ. Functional MRI of
visuospatial working memory in schizotypal personality disorder: a
region-of-interest analysis. Psychol Med 2005;35:1019–30.
44. Eliez S, Schmitt JE, White CD, Reiss AL. Children and
Adolescents with velo-cardio-facial syndrome: a volumetric MRI
study. Am J Psych 2000;157:409–15.
45. Kates WR, Burnette CP, Jabs EW, Rutberg J, Murphy AM,
Grados M, Geraghty M, Kaufmann WE, Pearlson GD. Regional
cortical white matter reductions in velocardiofacial syndrome: a
volumetric MRI analysis. Biol Psychiatry 2001;49:677–84.
46. van Amelsvoort T, Daly E, Robertson D, Suckling J, Ng V,
Critchley H, Owen MJ, Henry J, Murphy KC, Murphy DGM.
Structural brain abnormalities associated with deletion at chromo-
some 22q11: quantitative neuroimaging study of adults with velo-
cardio-facial syndrome. Br J Psychiatry 2001;178:412–9.
47. Campbell LE, Daly E, Toal F, Stevens A, Azuma R, Catani M, Ng
V, van Amelsvoort T, Chitnis X, Cutter W, Murphy DG, Murphy
KC. Brain and behaviour in children with 22q11.2 deletion
syndrome: a volumetric and voxel-based morphometry MRI
study. Brain 2006;129:1218–28.
48. Kates WR, Burnette CP, Bessette BA, Folley BS, Strunge L, Jabs
EW, Pearlson GD, Kates WR, Burnette CP, Bessette BA, Folley
BS, Strunge L, Jabs EW, Pearlson GD. Frontal and caudate
alterations in velocardiofacial syndrome (deletion at chromosome
22q11.2). J Child Neurol 2004;19:337–42.
49. Barnea-Goraly N, Eliez S, Menon V, Bammer R, Reiss AL.
Arithmetic ability and parietal alterations: a diffusion tensor
imaging study in velocardiofacial syndrome. Cogn Brain Res
2005;25:735–40.
50. Simon TJ, Ding L, Bish JP, McDonald-McGinn DM, Zackai EH,
Gee J, Simon TJ, Ding L, Bish JP, McDonald-McGinn DM, Zackai
EH, Gee J. Volumetric, connective, and morphologic changes in the
brains of children with chromosome 22q11.2 deletion syndrome: an
integrative study. Neuroimage 2005;25:169–80.
51. Wechsler D. Wechsler Intelligence Scales for children—third
edition. San Antonio, TX: The Psychological Corporation; 1991.
52. Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance
imaging with contrast dependent on blood oxygenation. Proc Natl
Acad Sci USA 1990;87:9868–72.
J Neurodevelop Disord (2009) 1:46–60 59
53. Brammer MJ, Bullmore ET, Simmons A, Williams SC, Grasby
PM, Howard RJ, Woodruff PW, Rabe-Hesketh S. Generic brain
activation mapping in functional magnetic resonance imaging:
a nonparametric approach. Magn Reson Imaging 1997;15:763–
70.
54. Bullmore ET, Brammer MJ, Rabe-Hesketh S, Curtis VA, Morris
RG, Williams SC, Sharma T, McGuire PK. Methods for diagnosis
and treatment of stimulus-correlated motion in generic brain
activation studies using fMRI. Hum Brain Mapp 1999;7:38–48.
55. Friman O, Borga M, Lundberg P, Knutsson H. Adaptive analysis
of fMRI data. Neuroimage 2003;19(3):837–45.
56. Bullmore E, Long C, Suckling J, Fadili J, Calvert G, Zelaya F,
Carpenter TA, Brammer M. Colored noise and computational
inference in neurophysiological (fMRI) time series analysis:
resampling methods in time and wavelet domains. Hum Brain
Mapp 2001;12(2):61–78.
57. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor
E, Brammer MJ. Global, voxel, and cluster tests, by theory and
permutation, for a difference between two groups of structural MR
images of the brain. IEEE Trans Med Imag 1999;18:32–42.
58. Talairach JTP. Co-planar stereotaxic atlas of the human brain.
New York: Thieme; 1988.
59. Eliez S, Blasey C, Menon V, White C, Schmitt J, Reiss A.
Functional brain imaging study of mathematical reasoning
abilities in velocardiofacial syndrome (del22q11.2). Genet Med
2001;3:49–55.
60. Awh E, Jonides J. Spatial working memory and spatial selective
attention. In: Parasuraman R, editor. The attentive brain. Cam-
bridge, MA: The MIT; 1998. p. 353–80. xii, 577.
61. Diwadkar VA, Carpenter PA, Just MA. Collaborative activity
between parietal and dorso-lateral prefrontal cortex in dynamic
spatial working memory revealed by fMRI. Neuroimage
2000;12:85–99.
62. Ungerleider LG, Courtney SM, Haxby JV. A neural system for
human visual working memory. Proc Natl Acad Sci USA
1998;95:883–90.
63. Caldu X, Vendrell P, Bartres-Faz D, Clemente I, Bargallo N,
Jurado MA, Serra-Grabulosa JM, Junque C. Impact of the COMT
Val108/158 Met and DAT genotypes on prefrontal function in
healthy subjects. Neuroimage 2007;37:1437–44.
64. McIntosh AM, Baig BJ, Hall J, Job D, Whalley HC, Lymer GKS,
Moorhead TWJ, Owens DGC, Miller P, Porteous D, Lawrie SM,
Johnstone EC. Relationship of catechol-O-methyltransferase var-
iants to brain structure and function in a population at high risk of
psychosis. Biol Psychiatry 2007;61:1127–34.
65. Ehlis A-C, Reif A, Herrmann MJ, Lesch K-P, Fallgatter AJ.
Impact of catechol-O-methyltransferase on prefrontal brain func-
tioning in schizophrenia spectrum disorders. Neuropsychophar-
macology 2007;32:162–70.
66. Bertolino A, Rubino V, Sambataro F, Blasi G, Latorre V, Fazio L,
Caforio G, Petruzzella V, Kolachana B, Hariri A, Meyer-
Lindenberg A, Nardini M, Weinberger DR, Scarabino T. Prefron-
tal–hippocampal coupling during memory processing is modulated
by COMT val158met genotype. Biol Psychiatry 2006;60:1250–8.
67. Blasi G, Mattay VS, Bertolino A, Elvevag B, Callicott JH, Das S,
Kolachana BS, Egan MF, Goldberg TE, Weinberger DR. Effect of
catechol-O-methyltransferase val158met genotype on attentional
control. J Neurosci 2005;25:5038–45.
68. Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T,
Kolachana BS, Goldman D, Weinberger DR. Executive subpro-
cesses in working memory: relationship to catechol-O-
methyltransferase Val158Met genotype and schizophrenia. Arch
Gen Psychiatry 2003;60:889–96.
69. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T,
Goldman D. A functional polymorphism in the COMT gene and
performance on a test of prefrontal cognition. Am J Psych
2002;159:652–4.
70. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti
CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT
Val108/158 Met genotype on frontal lobe function and risk for
schizophrenia. Proc Natl Acad Sci USA 2001;98:6917–22.
71. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X,
Goldman RS, Hoptman MJ, Sheitman B, Lindenmayer J-P, Citrome
L, McEvoy JP, Kunz M, Chakos M, Cooper TB, Lieberman JA.
Neurocognitive correlates of the COMT Val(158)Met polymorphism
in chronic schizophrenia. Biol Psychiatry 2002;52:701–7.
72. Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ,
McDonald-McGinn DM, Saitta SC, Harris SE, Moss E, Wang
PP, Zackai E, Emanuel BS, Simon TJ, Bearden CE, Jawad AF,
Lynch DR, Sokol S, Kanes SJ, McDonald-McGinn DM, Saitta
SC, Harris SE, Moss E, Wang PP, Zackai E, Emanuel BS, Simon
TJ. Effects of a functional COMT polymorphism on prefrontal
cognitive function in patients with 22q11.2 deletion syndrome.
Am J Psych 2004;161:1700–2.
73. Gothelf D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C,
KwonH, Jin S, Jo B, Antonarakis SE,MorrisMA, Reiss AL, Gothelf
D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C, Kwon
H, Jin S, Jo B, Antonarakis SE, Morris MA, Reiss AL. COMT
genotype predicts longitudinal cognitive decline and psychosis in
22q11.2 deletion syndrome. Nat Neurosci 2005;8:1500–2.
60 J Neurodevelop Disord (2009) 1:46–60
